Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperoxaluria”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)UnknownNCT03346369
What this trial is testing

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

Who this might be right for
Secondary HyperoxaluriaNephrolithiasis
Universitair Ziekenhuis Brussel 35
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableStudy completedNCT03095885
What this trial is testing

A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria

Who this might be right for
Secondary HyperoxaluriaNephrolithiasisHyperoxaluria+1 more
Allena Pharmaceuticals 22
Testing effectiveness (Phase 2)Ended earlyNCT04909723
What this trial is testing

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

Who this might be right for
Healthy VolunteersEnteric Hyperoxaluria
Novome Biotechnologies Inc 153
Testing effectiveness (Phase 2)Study completedNCT02547805
What this trial is testing

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days

Who this might be right for
Secondary HyperoxaluriaNephrolithiasisHyperoxaluria+2 more
Allena Pharmaceuticals 66
Testing effectiveness (Phase 2)Study completedNCT02503345
What this trial is testing

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones

Who this might be right for
Secondary HyperoxaluriaNephrolithiasisKidney Stones+2 more
Allena Pharmaceuticals 32